"This just one example of a situation where allowing derivatives may not be 
clearly beneficial. Others include situations where an author is using someone 
else's work and the someone else does not allow derivatives. It is often the 
case with book publishing that excerpts are taken from various places with a 
variety of rights attached. In this case, a policy requiring CC-BY places 
limitations on what an author can use in their work."

If the author does not allow derivatives, then you can't incorporate their work 
into your own without asking for special permission.
If you are going to ask for permission, you can ask for permission to make your 
derived use of the excerpt CC-BY. 

If need be (in cases where the author you want to reuse is unwilling or unable 
to allow CC-BY relicensing of the excerpt, but will allow you your particular 
reuse) you can make your own work CC-BY as a whole,  but with the excerpt 
annotated to indicate both its attribution (which is of course needed anyway) 
and that it (unlike the main body of your work) is under a CC-BY-ND license.

Licensing exceptions like this are routinely annotated within works ( both OA 
and non-OA publishers do this - it is very common to see a figure legend noting 
that copyright lies with another publisher).

It would be throwing the baby out with the bathwater, to put it mildly,  to 
block derivative in general, just to deal with this minor edge-case.

Matt Cockerill,
Managing Director, BioMed Central


-----Original Message-----
From: [email protected] [mailto:[email protected]] On Behalf Of 
Heather Morrison
Sent: Monday, August 20, 2012 7:07 PM
To: Global Open Access List (Successor of AmSci); SPARC Open Access Forum; 
open-science; [email protected] T.F.; [email protected]
Subject: [GOAL] CC-BY: derivatives and liability

Another question relating to policies requiring CC-BY licenses: will 
policy-makers require waiver of liability in the case of derivatives?

As an example of why this might be necessary: consider the scenario of a 
research article in the area of pharmacology. Someone creates a derivative - 
but makes a mistake on the dose. People die. 

Before we create and implement policies requiring that all scholars make their 
works available for re-use, in my opinion it would be wise to give considerable 
thought to whether there are good reasons why scholars may not always want to 
(or be able to) allow derivatives of their works.

This just one example of a situation where allowing derivatives may not be 
clearly beneficial. Others include situations where an author is using someone 
else's work and the someone else does not allow derivatives. It is often the 
case with book publishing that excerpts are taken from various places with a 
variety of rights attached. In this case, a policy requiring CC-BY places 
limitations on what an author can use in their work.

Note that I am in favor of libre OA, just convinced that this cannot be 
achieved by universal adoption of one particular CC license.

Heather Morrison, MLIS
Doctoral Candidate, Simon Fraser University School of Communication 
http://pages.cmns.sfu.ca/heather-morrison/
The Imaginary Journal of Poetic Economics http://poeticeconomics.blogspot.com





_______________________________________________
GOAL mailing list
[email protected]
http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal

_______________________________________________
GOAL mailing list
[email protected]
http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal

Reply via email to